drugset / Trial / NCT07547462

Optimizing Early Cesarean Scar Healing

NCT07547462 ↗

Completed 117 enrolled Hamad Medical Corporation
RandomizedParallel-groupSingle-blindTreatment

Summary

This randomized controlled trial compares hydrophilic methacrylate gel versus beta-sitosterol ointment for early cesarean section scar healing. Adult women who underwent cesarean delivery were randomly assigned to receive either hydrophilic methacrylate gel (n=58) or beta-sitosterol ointment (n=59). Scar outcomes were assessed by trained nurses blinded to treatment allocation and by patients at two time points approximately 12 days apart. The primary outcome was scar redness measured by the Vancouver Scar Scale. Secondary outcomes included pigmentation, pliability, scar height, and patient-reported measures including pain, itching, satisfaction, and treatment recommendation.

Timeline

Start
2023-12-15
Primary completion
2024-10-08
Completion
2024-11-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Beta-Sitosterol Unknown — Topical
Subject Hydrophilic Methacrylate Gel Unknown — Topical